EP3255043
N-(6-((2R,3S)-3,4-díhýdroxýbútan-2-ýloxý)-2-(4-flúorbensýlþíó)pýrimídín-4-ýl)-3-metýlasetidín-1-súlfónamíð sem flakkboðaviðtakastillir
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.7.2012EP published:
20.1.2021EP application number:
16202983.9
EP translation filed:
23.3.2021Grant published:
15.4.2021EPO information:
European Patent Register
Max expiry date:
9.7.2032Expiry date:
9.7.2023
Title:
N-(6-((2R,3S)-3,4-DIHYDROXYBUTAN-2-YLOXY)-2-(4-FLUOROBENZYLTHIO)PYRIMIDIN-4-YL)-3- METHYLAZETIDINE-1-SULFONAMIDE AS CHEMOKINE RECEPTOR MODULATOR
Timeline
Today
10.7.2012EP application
20.1.2021EP Publication
23.3.2021Translation submitted
15.4.2021Registration published
9.7.2023Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
CONNOLLY, StephenAddress:
Macclesfield, Cheshire SK10 4GT, GB
Name:
EBDEN, Mark, RichardAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
LANGER, ThomasAddress:
Macclesfield, Cheshire SK10 2NA, GB
Name:
STEVEN, Alan, RobertAddress:
Macclesfield, Cheshire SK10 2NA, GB
Name:
STEWART, Craig, RobertAddress:
Macclesfield, Cheshire SK10 2NA, GB
Name:
TOMLIN, Paula, MargaretAddress:
Macclesfield, Cheshire SK10 2NA, GB
Name:
WALTERS, Iain, Alastair, StewartAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
WILLIAMS, Andrew, JohnAddress:
Macclesfield, Cheshire SK10 4TG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161506737 PDate:
12.7.2011Country:
US
Classification
Categories:
C07D 403/12, C07D 205/04, A61K 31/506, A61P 37/00, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 29.6.2021
Expires: 9.7.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 21.6.2022
Expires: 9.7.2023
Payer: Patice ehf.